Ambys Medicines is focused on discovering and developing transformative therapies for people with advanced liver disease. The Company is engaged in creating breakthrough therapies capable of restoring liver function, preventing the progression of liver disease, and treating the devastating complications of liver failure.
|HQ||South San Francisco, US||Map|
|Employees (est.) (May 2020)||58||(+8%)|
Ambys Medicines total Funding
Ambys Medicines latest funding size
Time since last funding
|2 years ago|
Ambys Medicines investors
|Takeda Ventures, Third Rock Ventures|
When was Ambys Medicines founded?
Ambys Medicines was founded in 2018.
Who are Ambys Medicines key executives?
Ambys Medicines's key executives are Amanda Valentino, Glenn Pierce and Jeff Jonker.
How many employees does Ambys Medicines have?
Ambys Medicines has 58 employees.
Who are Ambys Medicines competitors?
Competitors of Ambys Medicines include Spark Therapeutics, Oxford BioTherapeutics and Annexon Biosciences.
Where is Ambys Medicines headquarters?
Ambys Medicines headquarters is located at 131 Oyster Point Blvd #200, South San Francisco.
Where are Ambys Medicines offices?
Ambys Medicines has an office in South San Francisco.
How many offices does Ambys Medicines have?
Ambys Medicines has 1 office.
Receive alerts for 300+ data fields across thousands of companies